Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pediatrix Medical GroupFRA:PDC -1.74%55 EV-to-OCF is 9.73 as of Aug. 01, 2026, which is 18% below its 10-year median of 11.83. GuruFocus rates FRA:PDC with a GF Score™ of 55/100 and a GF Value™ of €11.25. The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 53% on this metric.
The historical rank and industry rank for Pediatrix Medical Group's EV-to-OCF or its related term are showing as below:
FRA:PDC'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.28 Med: 11.83 Max: 149.35
Current: 9.58
During the past 13 years, the highest EV-to-OCF of Pediatrix Medical Group was 149.35. The lowest was 5.28. And the median was 11.83.
FRA:PDC's EV-to-OCF is ranked worse than 53% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.65
vs FRA:PDC: 9.58
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pediatrix Medical Group (FRA:PDC) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pediatrix Medical Group's PE Ratio (TTM) for today is calculated as:
Pediatrix Medical Group's share price for today is €22.60.
Pediatrix Medical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.768.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Pediatrix Medical Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's EV-to-OCF falls into.
Pediatrix Medical Group's current Enterprise Value is €2,150 Mil.
Pediatrix Medical Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €221 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a EV-to-OCF of 9.73 as of Aug. 01, 2026. This is 18% below median its historical median of 11.83. Over the past decade, Pediatrix Medical Group's EV-to-OCF has ranged from 5.28 to 149.35. According to the industry distribution chart, Pediatrix Medical Group ranks #362 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 53%.
Is Pediatrix Medical Group's EV-to-OCF too high?
Pediatrix Medical Group's current EV-to-OCF of 9.73 is 18% below median its 10-year median of 11.83. Over the past 10 years, this metric has ranged from a low of 5.28 to a high of 149.35. The Healthcare Providers & Services industry median EV-to-OCF is 8.65. Pediatrix Medical Group's value of 9.73 is 12.5% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #362 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's EV-to-OCF compare to ADUS and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #362 out of 683 companies for EV-to-OCF. This places Pediatrix Medical Group in the lower half of its industry. The industry median EV-to-OCF is 8.65. Pediatrix Medical Group's value of 9.73 is 12.5% above this benchmark. Historically, Pediatrix Medical Group's own EV-to-OCF has ranged from 5.28 to 149.35 over the past decade. While the company's 10-year median is 11.83 vs. the industry median of 8.65, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.65, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current EV-to-OCF of 9.73 is 12.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current EV-to-OCF is 9.73, which is 18% below median its own 10-year median of 11.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current EV-to-OCF of 9.73. The stock's GF Value™ is €11.25, compared to a current price of €22.60 — trading 100.9% above its estimated fair value. The current EV-to-OCF is 9.73, which is 18% below median its 10-year median of 11.83 and 12.5% above the Healthcare Providers & Services industry median of 8.65. Pediatrix Medical Group's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current EV-to-OCF is 9.73 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.60 is trading 100.9% above its estimated GF Value™ of €11.25.
Key valuation signals for FRA:PDC:
EV-to-OCF: 9.73 (18% below median its 10-year median of 11.83)
GF Value™: €11.25 vs. price of €22.60 (100.9% above fair value)
Industry Position: 12.5% above the Healthcare Providers & Services median (#362 of 683)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score
Get the complete analysis for FRA:PDC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
